Weiyi Wang

Person

New York, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof...
- Patent number 12,036,279
- Issue date Jul 16, 2024
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Replication competent attenuated vaccinia viruses with deletion of...
- Patent number 11,986,503
- Issue date May 21, 2024
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Replication competent attenuated vaccinia viruses with deletion of...
- Patent number 11,541,087
- Issue date Jan 3, 2023
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of inactivated nonreplicating modified vaccinia virus Ankara (M...
- Patent number 11,426,460
- Issue date Aug 30, 2022
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Recombinant MVA or MVAΔE3L expressing human FLT3L and use thereof a...
- Patent number 11,285,209
- Issue date Mar 29, 2022
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors
- Patent number 11,253,560
- Issue date Feb 22, 2022
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Replication competent attenuated vaccinia viruses with deletion of...
- Patent number 10,765,711
- Issue date Sep 8, 2020
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof...
- Patent number 10,736,962
- Issue date Aug 11, 2020
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of inactivated nonreplicating modified vaccinia virus Ankara (M...
- Patent number 10,639,366
- Issue date May 5, 2020
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors
- Patent number 10,548,930
- Issue date Feb 4, 2020
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Replication competent attenuated vaccinia viruses with deletion of...
- Patent number 10,512,662
- Issue date Dec 24, 2019
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
STING crystals and modulators
- Patent number 10,176,292
- Issue date Jan 8, 2019
- Memorial Sloan Kettering Cancer Center
- Dinshaw J. Patel
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
REPLICATION COMPETENT ATTENUATED VACCINIA VIRUSES WITH DELETION OF...
- Publication number 20230310526
- Publication date Oct 5, 2023
- Memorial Sloan-Kettering Cancer Center
- Liang DENG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RECOMBINANT MVA OR MVADELE3L EXPRESSING HUMAN FLT3L AND USE THEREOF...
- Publication number 20230057304
- Publication date Feb 23, 2023
- Memorial Sloan-Kettering Cancer Center
- Liang DENG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
REPLICATION COMPETENT ATTENUATED VACCINIA VIRUSES WITH DELETION OF...
- Publication number 20220339221
- Publication date Oct 27, 2022
- Memorial Sloan-Kettering Cancer Center
- Liang DENG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF MVA OR MVADELTAE3L AS IMMUNOTHERAPEUTIC AGENTS AGAINST SOLID...
- Publication number 20220211785
- Publication date Jul 7, 2022
- Memorial Sloan-Kettering Cancer Center
- Liang DENG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECOMBINANT POXVIRUSES FOR CANCER IMMUNOTHERAPY
- Publication number 20220056475
- Publication date Feb 24, 2022
- Memorial Sloan-Kettering Cancer Center
- Liang DENG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ONCOLYTIC VACCINIA VIRUS EXPRESSING IMMUNE CHECKPOINT BLOCKADE FOR...
- Publication number 20210023151
- Publication date Jan 28, 2021
- Memorial Sloan-Kettering Cancer Center
- Liang DENG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
VACCINIA VIRUS MUTANTS USEFUL FOR CANCER IMMUNOTHERAPY
- Publication number 20200339959
- Publication date Oct 29, 2020
- Memorial Sloan-Kettering Cancer Center
- Liang Deng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECOMBINANT MVA OR MVADELE3L EXPRESSING HUMAN FLT3L AND USE THEREOF...
- Publication number 20200316198
- Publication date Oct 8, 2020
- Memorial Sloan-Kettering Cancer Center
- Liang DENG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF INACTIVATED NONREPLICATING MODIFIED VACCINIA VIRUS ANKARA (M...
- Publication number 20200237902
- Publication date Jul 30, 2020
- Memorial Sloan-Kettering Cancer Center
- Liang Deng
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
REPLICATION COMPETENT ATTENUATED VACCINIA VIRUSES WITH DELETION OF...
- Publication number 20200237839
- Publication date Jul 30, 2020
- Memorial Sloan-Kettering Cancer Center
- Liang DENG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF MVA OR MVADELTAE3L AS IMMUNOTHERAPEUTIC AGENTS AGAINST SOLID...
- Publication number 20200222479
- Publication date Jul 16, 2020
- Memorial Sloan-Kettering Cancer Center
- Liang DENG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
REPLICATION COMPETENT ATTENUATED VACCINIA VIRUSES WITH DELETION OF...
- Publication number 20190054131
- Publication date Feb 21, 2019
- Memorial Sloan-Kettering Cancer Center
- Liang DENG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECOMBINANT MVA OR MVADELE3L EXPRESSING HUMAN FLT3L AND USE THEREOF...
- Publication number 20190046640
- Publication date Feb 14, 2019
- Memorial Sloan-Kettering Cancer Center
- Liang DENG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF INACTIVATED NONREPLICATING MODIFIED VACCINIA VIRUS ANKARA (M...
- Publication number 20180236062
- Publication date Aug 23, 2018
- Memorial Sloan-Kettering Cancer Center
- Liang Deng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF MVA OR MVADELTAE3L AS IMMUNOTHERAPEUTIC AGENTS AGAINST SOLID...
- Publication number 20180078591
- Publication date Mar 22, 2018
- Memorial Sloan-Kettering Cancer Center
- Liang DENG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
STING CRYSTALS AND MODULATORS
- Publication number 20160210400
- Publication date Jul 21, 2016
- Memorial Sloan-Kettering Cancer Center
- Dinshaw J. Patel
- G01 - MEASURING TESTING

Person

Patents Grantslast 30 patents

Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof...

Replication competent attenuated vaccinia viruses with deletion of...

Replication competent attenuated vaccinia viruses with deletion of...

Use of inactivated nonreplicating modified vaccinia virus Ankara (M...

Recombinant MVA or MVAΔE3L expressing human FLT3L and use thereof a...

Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors

Replication competent attenuated vaccinia viruses with deletion of...

Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof...

Use of inactivated nonreplicating modified vaccinia virus Ankara (M...

Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors

Replication competent attenuated vaccinia viruses with deletion of...

STING crystals and modulators

Patents Applicationslast 30 patents

REPLICATION COMPETENT ATTENUATED VACCINIA VIRUSES WITH DELETION OF...

RECOMBINANT MVA OR MVADELE3L EXPRESSING HUMAN FLT3L AND USE THEREOF...

REPLICATION COMPETENT ATTENUATED VACCINIA VIRUSES WITH DELETION OF...

USE OF MVA OR MVADELTAE3L AS IMMUNOTHERAPEUTIC AGENTS AGAINST SOLID...

RECOMBINANT POXVIRUSES FOR CANCER IMMUNOTHERAPY

ONCOLYTIC VACCINIA VIRUS EXPRESSING IMMUNE CHECKPOINT BLOCKADE FOR...

VACCINIA VIRUS MUTANTS USEFUL FOR CANCER IMMUNOTHERAPY

RECOMBINANT MVA OR MVADELE3L EXPRESSING HUMAN FLT3L AND USE THEREOF...

USE OF INACTIVATED NONREPLICATING MODIFIED VACCINIA VIRUS ANKARA (M...

REPLICATION COMPETENT ATTENUATED VACCINIA VIRUSES WITH DELETION OF...

USE OF MVA OR MVADELTAE3L AS IMMUNOTHERAPEUTIC AGENTS AGAINST SOLID...

REPLICATION COMPETENT ATTENUATED VACCINIA VIRUSES WITH DELETION OF...

RECOMBINANT MVA OR MVADELE3L EXPRESSING HUMAN FLT3L AND USE THEREOF...

USE OF INACTIVATED NONREPLICATING MODIFIED VACCINIA VIRUS ANKARA (M...

USE OF MVA OR MVADELTAE3L AS IMMUNOTHERAPEUTIC AGENTS AGAINST SOLID...

STING CRYSTALS AND MODULATORS